SGLT2 inhibitor empagliflozin safe and effective for treating patients who have suffered MI: EMPACT-MI, ESC 2024 Dr. Kamal Kant Kohli3 Sept 2024 10:30 AM ISTThe SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Empagliflozin plus Sitagliptin FDC Dr. Divya Colin28 Aug 2024 6:15 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
SGLT2 inhibitors reduce arrhythmias risk in patients with type 2 diabetes: BMC study Jacinthlyn Sylvia12 July 2024 9:30 AM ISTA new study published in the recent issue of BMC Cardiovascular Diabetology journal found that in individuals with type 2 diabetes who...
Lupin secures USFDA tentative nod for Empagliflozin, Linagliptin and Metformin Hydrochloride ER tablets Ruchika Sharma10 July 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Empagliflozin Use Leads to Rare Case of Emphysematous Cystitis in Non-Diabetic Patient: Case Study Medha Baranwal8 July 2024 8:30 AM ISTMalta: A recent case study published in Cureus Journal has described a rare medical case in which the use of empagliflozin, a medication typically...
Glyceraldehyde derivatives inspired by empagliflozin potential anti-heart failure agents independent of glucose-lowering effects: Study Dr. Kamal Kant Kohli16 May 2024 8:15 AM ISTHeart failure (HF) is a complex clinical syndrome characterized by high mortality and frequent hospitalizations. HF significantly affected the quality...
Empagliflozin Shows Promise for Alleviating Peripheral Diabetic Neuropathy in Type 2 Diabetes Patients: Study Medha Baranwal7 May 2024 10:00 AM ISTEgypt: In a significant development for type 2 diabetes mellitus (T2DM) management, a recent study has uncovered promising evidence regarding the...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
Exemed Pharmaceutical Gets CDSCO Panel Nod to Study Empagliflozin plus Glimepiride plus Metformin FDC Dr. Divya Colin7 April 2024 5:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Combination of empagliflozin and citalopram effective against major depressive disorder: Study Medha Baranwal2 April 2024 4:00 AM ISTIran: Combination therapy of empagliflozin and citalopram is effective in reducing symptom severity in patients with major depressive disorder, a...
Zydus Healthcare gets CDSCO Panel Nod To study FDC Empagliflozin plus Metoprolol Succinate Dr. Divya Colin10 March 2024 5:45 PM ISTNew Delhi: The drug major Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Synokem Pharma Gets CDSCO Panel Nod To Study Antidiabetic FDC Dr. Divya Colin27 Feb 2024 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
